MetLife, Inc. MET

97.70 0.45 0.46% as of 25 Sep
Market cap
$61.6B
P/E
18.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

MetLife, Inc. (MET) EBITDA

MetLife, Inc.'s EBITDA for fiscal 2025 was $3.6B, down 25.9% from $4.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.9B. Over the past ten years it has ranged from $1.5B (fiscal 2023) to $8.3B (fiscal 2021); the current reading is higher than 27% of that period. MetLife, Inc. ranks 2nd of 16 Insurance Life companies by EBITDA.

EBITDA, annual

Annual

Period EBITDA Change
FY2025 $3.6B (25.91%)
FY2024 $4.8B 211.63%
FY2023 $1.5B (74.39%)
FY2022 $6.0B (27.50%)
FY2021 $8.3B 23.89%
FY2020 $6.7B 4.73%
FY2019 $6.4B 8.51%
FY2018 $5.9B 80.16%
FY2017 $3.3B (14.02%)
FY2016 $3.8B (26.52%)

Quarterly

Period EBITDA Change
Jun 2026 $1.0B (31.32%)
Mar 2026 $1.5B 34.91%
Dec 2025 $1.1B (7.69%)
Sep 2025 $1.2B 23.47%
42 more quarters

Against its own ten years

Low $1.5B High $8.3B
Ten-year median $5.2B
Current reading's percentile 27

EBITDA against peers

What EBITDA is

EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.

Reported line item

The full definition of EBITDA →

More on MET